On April 12, 2023, Aprogen Biologics Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,019 KRW | -2.21% |
|
-10.61% | -64.86% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,055 KRW | -12.74% | -17.71% | 221M | ||
1,019 KRW | -2.21% | -10.61% | 49.32M | ||
1st Jan change | Capi. | |
---|---|---|
-64.86% | 49.32M | |
+51.75% | 798B | |
+41.51% | 633B | |
-4.98% | 356B | |
+19.16% | 328B | |
+10.21% | 304B | |
+17.66% | 244B | |
+3.39% | 227B | |
+10.75% | 216B | |
+7.60% | 166B |
- Stock Market
- Equities
- A003060 Stock
- News Aprogen Biologics Inc.
- Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.